Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
1.800
-0.040 (-2.17%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $231.61 million as of August 21, 2026. Its market cap has decreased by -60.14% in one year.
Market Cap
231.61M
Enterprise Value
252.47M
1-Year Change
-60.14%
Ranking
Category
Stock Price
$1.80
ChartMarket Cap Chart
Since January 8, 2019, Organogenesis Holdings's market cap has decreased from $1.24B to $231.61M, a decrease of -81.27%. That is a compound annual growth rate of -19.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 231.61M | -64.77% |
| Dec 31, 2025 | 657.40M | 63.40% |
| Dec 31, 2024 | 402.32M | -25.09% |
| Dec 29, 2023 | 537.07M | 52.51% |
| Dec 30, 2022 | 352.16M | -70.37% |
| Dec 31, 2021 | 1.19B | 23.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alpha Teknova | 395.15M |
| Anika Therapeutics | 291.48M |
| Emergent BioSolutions | 260.47M |
| Aurora Cannabis | 254.85M |
| Akebia Therapeutics | 251.22M |
| Cardiol Therapeutics | 218.90M |
| Journey Medical | 218.74M |
| SIGA Technologies | 218.42M |